Atlas Trials

Gastric or Gastroesophageal Junction Adenocarcinoma

23 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Gastric or Gastroesophageal Junction Adenocarcinoma

RecordFirmDate
SOX Combined With Sintilimab and Trastuzumab Versus SOX Regimen in the Perioperative Treatment of HER2-positive Locally Advanced Gastric Adenocarcinoma (NCT05218148)Aiping Zhou2022-04-01
Efficacy and Safety of Neoadjuvant Nivolumab Plus SOX Versus Nivolumab Plus FLOT in Patients With HER2-negative Gastric and Gastroesophageal Junction Adenocarcinoma (NCT06440811)Xijing Hospital2021-01-01
Retrospective Study of Ramucirumab and Paclitaxel in Gastric or Gastroesophageal Junction Adenocarcinoma (NCT04192734)Hallym University Medical Center2019-12-18
PD-1 Antibody + XELOX in 1st Line Serum A-fetoprotein (AFP)-Elevated Gastric or Gastroesophageal Junction Adenocarcinoma (NCT04098796)China Medical University, China2019-10-01
A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors (NCT03849469)Xencor, Inc.2019-05-29
A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3) (NCT03752398)Xencor, Inc.2019-05-01
Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction Carcinoma (NCT03777657)BeiGene2018-12-13
A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors (NCT03517488)Xencor, Inc.2018-07-10
A Phase 1b/2 Study of MEDI4736 With Tremelimumab, MEDI4736 or Tremelimumab Monotherapy in Gastric or GEJ Adenocarcinoma (NCT02340975)MedImmune LLC2015-03-31

Track Gastric or Gastroesophageal Junction Adenocarcinoma automatically

Every clearance here is in the API, with alerts when new ones post.